Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
Alessandra Biffi,
Eugenio Montini,
Laura Lorioli,
Martina Cesani,
Francesca Fumagalli,
Tiziana Plati,
Cristina Baldoli,
Sabata Martino,
Andrea Calabria,
Sabrina Canale,
Fabrizio Benedicenti,
Giuliana Vallanti,
Luca Biasco,
Simone Leo,
Nabil Kabbara,
Gianluigi Zanetti,
William B. Rizzo,
Nalini A. L. Mehta,
Maria Pia Cicalese,
Miriam Casiraghi,
Jaap J. Boelens,
Ubaldo Del Carro,
David J. Dow,
Manfred Schmidt,
Andrea Assanelli,
Victor Neduva,
Clelia Di Serio,
Elia Stupka,
Jason Gardner,
Christof von Kalle,
Claudio Bordignon,
Fabio Ciceri,
Attilio Rovelli,
Maria Grazia Roncarolo,
Alessandro Aiuti,
Maria Sessa,
Luigi Naldini
Science, Volume 341, Number 6148, page 1233158 - august 2013
Metachromatic leukodystrophy (MLD) is an inherited lysosomal storage disease caused by arylsulfatase A (ARSA) deficiency. Patients with MLD exhibit progressive motor and cognitive impairment and die within a few years of symptom onset. We used a lentiviral vector to transfer a functional ARSA gene into hematopoietic stem cells (HSCs) from three presymptomatic patients who showed genetic, biochemical, and neurophysiological evidence of late infantile MLD. After reinfusion of the gene-corrected HSCs, the patients showed extensive and stable ARSA gene replacement, which led to high enzyme expression throughout hematopoietic lineages and in cerebrospinal fluid. Analyses of vector integrations revealed no evidence of aberrant clonal behavior. The disease did not manifest or progress in the three patients 7 to 21 months beyond the predicted age of symptom onset. These findings indicate that extensive genetic engineering of human hematopoiesis can be achieved with lentiviral vectors and that this approach may offer therapeutic benefit for MLD patients.
Références BibTex
@Article{BMLCFPBMCCBVBLKZRMCCBDDSANDSGVBCRRASN13,
author = {Biffi, A. and Montini, E. and Lorioli, L. and Cesani, M. and Fumagalli, F. and Plati, T. and Baldoli, C. and Martino, S. and Calabria, A. and Canale, S. and Benedicenti, F. and Vallanti, G. and Biasco, L. and Leo, S. and Kabbara, N. and Zanetti, G. and Rizzo, W. and Mehta, N. and Cicalese, M. and Casiraghi, M. and Boelens, J. and Del Carro, U. and Dow, D. and Schmidt, M. and Assanelli, A. and Neduva, V. and Di Serio, C. and Stupka, E. and Gardner, J. and von Kalle, C. and Bordignon, C. and Ciceri, F. and Rovelli, A. and Roncarolo, M. and Aiuti, A. and Sessa, M. and Naldini, L.},
title = {Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy},
journal = {Science},
number = {6148},
volume = {341},
pages = {1233158},
month = {august},
year = {2013},
publisher = {AAAS},
keywords = {gene therapy, stem cells},
doi = {10.1126/science.1233158},
url = {https://publications.crs4.it/pubdocs/2013/BMLCFPBMCCBVBLKZRMCCBDDSANDSGVBCRRASN13},
}
Autres publications dans la base